Arrowstreet Capital, Limited Partnership »

Sutro Biopharma shares owned by Arrowstreet Capital, Limited Partnership

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Arrowstreet Capital, Limited Partnership from 13F filings

Historical chart of Arrowstreet Capital, Limited Partnership investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Arrowstreet Capital, Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6M 738k 3.46
2024-06-30 $40k 14k 2.93
2021-03-31 $621k 27k 22.75
2020-06-30 $97k 12k 7.80

More positions owned by Arrowstreet Capital, Limited Partnership

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Meta Platforms Cl A (META)
At&t (T)
Eli Lilly & Co. (LLY)
Wells Fargo & Company (WFC)
JPMorgan Chase & Co. (JPM)
General Motors Company (GM)
Bank of America Corporation (BAC)
Comcast Corp Cl A (CMCSA)
Altria (MO)
MercadoLibre (MELI)
Hca Holdings (HCA)
Netflix (NFLX)

View all positions for Arrowstreet Capital, Limited Partnership

Top funds holding Sutro Biopharma

Suvretta Capital Management
BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
Point72 Asset Management
Samsara BioCapital
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Parkman Healthcare Partners
Acadian Asset Management
State Street Corporation
Baillie Gifford & Co
Goldman Sachs Group

View all funds holding Sutro Biopharma